JCTLM Newsletter – Special Issue 2020: Member and Stakeholder Activities on COVID -19
Publications:
- Aloisio E et al. A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity. Arch Pathol Lab Med 2020;144(12):1457-1464
- Panteghini M. Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only). Clin Chem Lab Med 2020;58(12):1979–1981
- Aloisio E et al. Linking lactate dehydrogenase to the severity of COVID-19 cannot ignore the employed methodology. Am J Emerg Med 2021;45:652-653
- Dolci A et al. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients. Clin Chem Lab Med 2020;59(2):433-440
- Aloisio E et al. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization. Clin Chem Lab Med 2020;58(11):e255–e256
- Pasqualetti S et al. Serum albumin in COVID-19: a good example in which analytical and clinical performance of a laboratory test are strictly intertwined. Hepatology 2021;74(5):2905-2907
- Aloisio E et al. SARS-CoV-2 serologic tests: do not forget the good laboratory practice. Clin Chem Lab Med 2020;59(5):e175-e177
- Szoke D et al. Serum potassium concentrations in COVID-19. Clin Chim Acta 2021;512:26-27
- Aloisio E et al. Sources and clinical significance of aspartate aminotransferase increases in COVID-19. Clin Chim Acta 2021;522:88-95
- Aloisio E, Panteghini M. Aspartate aminotransferase in COVID-19: A probably overrated marker. Liver Int 2021;41(11):2809-2810
- Caruso S et al. Lipase elevation in serum of COVID-19 patients: frequency, extent of increase and clinical value. Clin Chem Lab Med 2021;60(1):135-142